Citation Tools

Original research
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Download to a citation manager

Cite this article as:
Monge C, Xie C, Myojin Y, et al
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer